Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06995521
What this trial is testing

Vorinostat for Graft-versus-host Disease (GVHD) Prevention in Non-Malignant Adolescent and Young Adults (AYA) Population

Who this might be right for
GVHD
Sung Won Choi 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT04572815
What this trial is testing

Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant

Who this might be right for
Hematologic and Lymphocytic DisorderHematopoietic and Lymphoid System Neoplasm
Fred Hutchinson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT03270748
What this trial is testing

Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
Gruppo Italiano Trapianto di Midollo Osseo 78
Not applicableEnrolling By InvitationNCT06698211
What this trial is testing

Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD

Who this might be right for
Invasive Fungal DiseaseGraft Versus Host DiseaseHematopoietic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 40
Testing effectiveness (Phase 2)Study completedNCT03434730
What this trial is testing

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Leukemia+6 more
Memorial Sloan Kettering Cancer Center 46
Early research (Phase 1)Study completedNCT00001830
What this trial is testing

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseHodgkin's Disease+2 more
National Cancer Institute (NCI) 110
Testing effectiveness (Phase 2)UnknownNCT01385124
What this trial is testing

Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Rabin Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06128070
What this trial is testing

Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT07724873
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients

Who this might be right for
Hematopoietic Stem Cell Transplant (HSCT)GVHD - Graft-Versus-Host DiseaseHematological Malignancy
Tata Memorial Centre 54
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Ended earlyNCT00968864
What this trial is testing

T-cell Depleted Alternative Donor Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myeloid Leukemia+6 more
Wake Forest University Health Sciences 53
Not applicableStudy completedNCT03204721
What this trial is testing

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

Who this might be right for
Graft-Versus-Host Disease
Oslo University Hospital 158
Testing effectiveness (Phase 2)Study completedNCT00189748
What this trial is testing

Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Who this might be right for
Bone Marrow TransplantationGraft Versus Host DiseaseGraft-Versus-Host Disease+1 more
Astellas Pharma Inc
Testing effectiveness (Phase 2)Study completedNCT02588339
What this trial is testing

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Who this might be right for
Graft Versus Host DiseaseGVHD
H. Lee Moffitt Cancer Center and Research Institute 42
Early research (Phase 1)WithdrawnNCT02528877
What this trial is testing

Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

Who this might be right for
Acute Myeloid Leukemia in RemissionPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic Stage+2 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT04473911
What this trial is testing

Haplo Peripheral Blood Sct In GVHD Prevention

Who this might be right for
GVHDAMLALL+13 more
Zachariah Michael DeFilipp 25
Testing effectiveness (Phase 2)Study completedNCT01713400
What this trial is testing

Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Graft vs. Host Disease
H. Lee Moffitt Cancer Center and Research Institute 54
Large-scale testing (Phase 3)Study completedNCT00210873
What this trial is testing

An Open Label Extension of a Study of Topiramate in Chronic Migraine.

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 200
Testing effectiveness (Phase 2)Study completedNCT02172768
What this trial is testing

Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAllogeneic Stem Cell TransplantAcute Myeloid Leucaemia+1 more
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00282282
What this trial is testing

Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseGVHD
Dana-Farber Cancer Institute 31
Next Page